Saturday, 27 April 2024
Arena Pharmaceuticals Inc.
-
Overlay
-
Indicators
-
Settings
-
Period
23:18 | 19/3/18
Post Analyst
Friday seemed like a heavier volume day for CME Group Inc. (NASDAQ:CME), but it might not be harder to recover from. Trade volumes increased to 7.74 million shares compared with 90-day average tally of 1.62 million shares per day.
more»
00:26 | 19/3/18
Macon Daily
Arena Pharmaceuticals, Inc. logo Needham & Company LLC reissued their hold rating on shares of Arena Pharmaceuticals (NASDAQ:ARNA) in a report published on Wednesday.
more»
Take Note: Arena Pharmaceuticals Inc (NASDAQ:ARNA) has hit some technical weakness in its momentum, and while it has not broken down all the way through support -- watch the key levels that we discuss below and further, watch the stochastics and ...
more»
10:30 | 16/3/18
Equities.com
Arena Pharmaceuticals Inc. (ARNA) had a rough trading day for Thursday March 15 as shares tumbled 8.38%, or a loss of $-3.02 per share, to close at $33.01.
more»
10:30 | 16/3/18
Equities.com
Arena Pharmaceuticals Inc. (ARNA) traded on unusually high volume on Mar. 15, as the stock lost 8.38% to close at $33.01. On the day, Arena Pharmaceuticals Inc. saw 2.02 million shares trade hands on 14,671 trades. Considering that the stock averages ...
more»
In trading on Thursday, shares of Arena Pharmaceuticals Inc (Symbol: ARNA) entered into oversold territory, hitting an RSI reading of 28.7, after changing hands as low as $31.55 per share.
more»
However, the top line beat the Zacks Consensus Estimate of $4 million. Revenues include $14.2 million from collaboration revenues and $1.2 million in royalty revenues under a collaboration agreement with Japanese pharma company Eisai for Arena's ...
more»
Arena Pharmaceuticals Inc (Symbol: ARNA) options are showing a volume of 3,842 contracts thus far today. That number of contracts represents approximately 384,200 underlying shares, working out to a sizeable 70.7% of ARNA's average daily trading volume ...
more»
02:41 | 15/3/18
Zacks.com
San Diego, CA-based Arena Pharmaceuticals, Inc. (ARNA - Free Report) is a biopharmaceutical company whose only approved product is obesity treatment, Belviq (lorcaserin).
more»
Don't be caught off-guard: Arena Pharmaceuticals (NASDAQ: ARNA) releases its next round of earnings Tuesday. Want to skip the homework and get all the facts in one place?
more»